Information  X 
Enter a valid email address

SkinBioTherapPLC Ord 1P (SBTX)

Date Time Source Announcement
13 Jun 2022 3:37 pm
RNS
Stmnt re Share Price Movement
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
26 May 2022 2:02 pm
RNS
Change of Registered Office
27 Apr 2022 7:00 am
RNS
Confirmation of Directorate Appointments
29 Mar 2022 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Half-year Report
28 Mar 2022 7:00 am
RNS
Directorate Change
22 Mar 2022 2:00 pm
RNS
Investor Presentation - Interim Financial Results
16 Mar 2022 7:00 am
RNS
Notice of Results
17 Feb 2022 7:00 am
RNS
Business update
08 Feb 2022 11:20 am
RNS
Holding(s) in Company
18 Jan 2022 7:00 am
RNS
Directorate Change
12 Jan 2022 7:00 am
RNS
Grant of share options
23 Dec 2021 2:00 pm
RNS
Result of AGM
21 Dec 2021 2:00 pm
RNS
Annual General Meeting 2021 - Change of Venue
14 Dec 2021 7:00 am
RNS
Holding(s) in Company
06 Dec 2021 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
30 Nov 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:06 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Full year results
26 Nov 2021 4:12 pm
RNS
Notice of Results
15 Nov 2021 4:59 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Placing of Shares
29 Oct 2021 4:40 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Commercial Launch of AxisBiotix-PsT
15 Oct 2021 9:00 am
RNS
Investor Presentation
30 Sep 2021 7:00 am
RNS
AxisBiotix-PsT Psoriasis Food Supplement Launch
07 Sep 2021 7:00 am
RNS
Holding(s) in Company
19 Aug 2021 11:00 am
RNS
Business Update - Correction
26 May 2021 11:10 am
RNS
Holding(s) in Company
  7:00 am
RNS
Positive data for AxisBiotix-PsT consumer study
18 May 2021 11:00 am
RNS
Price Monitoring Extension
27 Apr 2021 7:00 am
RNS
Initiation of oral health development programme
19 Apr 2021 3:09 pm
RNS
Holding(s) in Company
12 Apr 2021 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
08 Apr 2021 7:00 am
RNS
Research programme with University of Manchester
06 Apr 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  2:06 pm
RNS
Second Price Monitoring Extn
  2:01 pm
RNS
Price Monitoring Extension
18 Mar 2021 2:02 pm
RNS
Holding(s) in Company
16 Mar 2021 5:42 pm
RNS
Holding(s) in Company
  10:50 am
RNS
Holding(s) in Company
15 Mar 2021 1:43 pm
RNS
Exercise of Warrant
  7:00 am
RNS
Half-year Report
12 Mar 2021 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
17 Feb 2021 11:36 am
RNS
AxisBiotix-PsT food supplement study commences
09 Feb 2021 1:04 pm
RNS
Holding(s) in Company
05 Feb 2021 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
01 Feb 2021 11:21 am
RNS
Holding(s) in Company
  7:00 am
RNS
Expanded enrolment for AxisBiotix-PsT study
25 Jan 2021 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
22 Jan 2021 4:40 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
21 Jan 2021 1:49 pm
RNS
Holding(s) in Company
19 Jan 2021 3:14 pm
RNS
Holding(s) in Company
18 Jan 2021 4:08 pm
RNS
Holding(s) in Company
13 Jan 2021 7:00 am
RNS
Enrolment for AxisBiotix-PsT study commences
11 Jan 2021 11:06 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
07 Jan 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
30 Dec 2020 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
29 Dec 2020 2:06 pm
RNS
Second Price Monitoring Extn
  2:01 pm
RNS
Price Monitoring Extension
  12:59 pm
RNS
Result of AGM
04 Dec 2020 4:44 pm
RNS
Director Dealing
  7:00 am
RNS
Final Results
02 Dec 2020 11:16 am
RNS
Notice of Results
02 Nov 2020 4:15 pm
RNS
Holding(s) in Company
  3:49 pm
RNS
Holding(s) in Company
30 Oct 2020 12:23 pm
RNS
Result of General Meeting and Open Offer
14 Oct 2020 7:00 am
RNS
Placing and Open Offer
18 Sep 2020 4:48 pm
RNS
Grant of Options
08 Sep 2020 7:19 am
RNS
Appointment of Senior Medical Advisor
31 Jul 2020 7:00 am
RNS
Product Development Progress
07 Jul 2020 7:00 am
RNS
Business Update
26 Jun 2020 7:00 am
RNS
Change of Adviser
23 Jun 2020 4:29 pm
RNS
Holding(s) in Company
01 Jun 2020 3:45 pm
RNS
Holding(s) in Company
17 Apr 2020 4:24 pm
RNS
Holding(s) in Company
17 Mar 2020 4:42 pm
RNS
Second Price Monitoring Extn
  4:38 pm
RNS
Price Monitoring Extension
03 Mar 2020 7:00 am
RNS
Half Year Results
19 Feb 2020 7:00 am
RNS
Agreement signed with Winclove Probiotics B.V.
19 Dec 2019 11:47 am
RNS
Result of AGM
26 Nov 2019 8:50 am
RNS
Notice of AGM
  7:00 am
RNS
Final Results
20 Nov 2019 7:00 am
RNS
Commercial Agreement
06 Nov 2019 10:38 am
RNS
Holding(s) in Company
28 Aug 2019 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Holding(s) in Company
04 Jul 2019 7:00 am
RNS
Business Update and Board Changes
18 Apr 2019 7:00 am
RNS
Director Appointment
16 Apr 2019 7:00 am
RNS
Director/PDMR Shareholding
08 Apr 2019 7:00 am
RNS
SkinBiotix shows efficacy in first human study
29 Mar 2019 7:00 am
RNS
CEO Designate Appointment
18 Feb 2019 7:00 am
RNS
Issue of Equity
14 Feb 2019 7:00 am
RNS
Half year results
01 Feb 2019 3:30 pm
RNS
Appointment of Joint Broker
31 Jan 2019 8:35 am
RNS
Update on human study and IP portfolio extension
  7:00 am
RNS
Update on human studies & IP portfolio extension
20 Nov 2018 7:00 am
RNS
Commencement of final phase of human studies
19 Nov 2018 12:30 pm
RNS
Result of AGM
07 Nov 2018 7:00 am
RNS
SkinBiotix? generates positive data in human study
25 Oct 2018 7:00 am
RNS
Full year results
19 Sep 2018 7:00 am
RNS
Human study commenced
18 Sep 2018 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
03 Sep 2018 7:00 am
RNS
SkinBiotix technology successful in stability test
16 Aug 2018 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Business Update
03 Aug 2018 8:57 am
RNS
Holding(s) in Company
23 Jul 2018 1:13 pm
RNS
Holding(s) in Company
18 Jul 2018 7:00 am
RNS
Provisional ethics approval for human study
29 May 2018 7:00 am
RNS
SkinBioTherapeutics involved in new research grant
14 May 2018 7:00 am
RNS
SkinBioTherapeutics files new patent application
01 May 2018 7:00 am
RNS
SkinBioTherapeutics plans for human study
24 Apr 2018 8:56 am
RNS
Holding(s) in Company
17 Apr 2018 7:00 am
RNS
Positive cream formulation results for SkinBiotix
03 Apr 2018 7:00 am
RNS
SBTX signs MTA with global consumer goods company
21 Feb 2018 7:00 am
RNS
Half year results
16 Feb 2018 10:02 am
RNS
Notice of Interim Results
05 Jan 2018 7:00 am
RNS
Appointment of Joint Broker
01 Dec 2017 7:05 am
RNS
Notification of first patent grant
09 Nov 2017 7:00 am
RNS
SkinBiotix platform passes external toxicity tests
08 Nov 2017 11:32 am
RNS
SkinBioTherapeutics to present at investor evening
30 Oct 2017 11:23 am
RNS
Result of AGM
05 Oct 2017 7:00 am
RNS
Final Results
03 Oct 2017 7:00 am
RNS
Cytotoxicity results and scientific update
27 Sep 2017 9:00 am
RNS
Notice of Results
12 Sep 2017 8:54 am
RNS
Holding(s) in Company
19 Jun 2017 9:00 am
RNS
SkinBioTherapeutics to Present at Investor Evening
09 Jun 2017 10:38 am
RNS
Holding(s) in Company
23 May 2017 3:21 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Extension of Research Contract
05 Apr 2017 7:00 am
RNS
First day of dealings - to trade under SBTX ticker

a d v e r t i s e m e n t